Myka Labs to exhibit at leading surgical society meeting

American Pediatric Surgical Association annual meeting

Myka Labs, developer of the revolutionary GlintTM smart catheter technology for treating serious conditions affecting the bowel, pancreas and other abdominal organs, today announced that it would exhibit at the upcoming American Pediatric Surgical Association (APSA) annual meeting.

At APSA, members of the Myka Labs team will offer hands-on demos with the company’s latest products and technology for endoscopic procedures, with advanced AI-powered functionality including visualization of hidden anatomy, real-time calculation of the extent of hollow organ dilation and other key parameters, and tool deployment assessment. By using Glint smart catheters and Myka’s accompanying AI-powered visualization environment, teams performing advanced endoscopic procedures can realize benefits including streamlined procedures, higher rates of achieving desired procedure outcomes, and expanded patient populations eligible for potentially life-saving endoscopic interventions.

Bringing to market high-clinical-impact solutions for conditions affecting pediatric patient populations is central to Myka Labs’ mission, with multiple pediatric products in the Myka Labs pipeline alongside products for conditions like pancreatic cancer. Myka Labs is commercializing Connect-EATM, a high-performance device system developed at UCSF Surgical Innovations for use by pediatric surgeons in repairing congenial malformations affecting the esophagus and windpipe. In publications appearing in leading journals, exceptionally favorable results have been reported for patients who have undergone Connect-EA procedures.

APSA will take place at the Fairmont Queen Elizabeth in Montreal, Canada from May 7-10, 2025.

Presentation at pediatric surgery conference highlights recent Connect-EA clinical experience

At the Western Medical Research Conference held this week in Carmel, California, UCSF’s Dr. Jackie Kading presented the latest results of clinical experience with Connect-EATM for birth defects involving the esophagus.

Dr. Kading’s talk compiled results from sixteen cases where Connect-EA was used. The cases were performed at leading children’s hospitals in the U.S. and Germany.

The neonates who underwent the Connect-EA procedure had concomitant conditions including single ventricle congenital heart disease, extreme prematurity, low birth weight and genetic syndromes.

Potential benefits for patients seen in analysis of the latest results with Connect-EA include sparing thoracotomy and protection against post-anastomotic stricture. The reduced rate of post-anastomotic stricture is particularly striking when compared to first-generation esophageal magnetic compression anastomosis (EMCA) systems.

Originally developed within the renowned Surgical Innovations program at the University of California at San Francisco, Connect-EA is now being transitioned to Myka Labs to spearhead the process of securing broad regulatory approvals and ensuring that Connect-EA is available to patients across the world who can potentially benefit from it.

Myka Labs participates in IMPACT1 summit for advancing innovation in pediatric and maternal health

CEOs of leading companies with products in pediatric and maternal health, including Dan Laser of Myka Labs, gathered at the Stanford Byers Center for Biodesign for a day of in-depth discussion around shared priorities.

At the event, hosted by Impact1, topics were wide-ranging, with regulatory policy an area of significant focus. The group formulated key framework elements for engagement with policymakers around pediatric and maternal health.

Participants also discussed growing opportunities to advance pediatric and maternal health within the setting of a high-growth, venture-backed startup. Myka’s pipeline of products built around its combination of advanced sensor technology and sophisticated real-time image analysis, including Connect for neonatal esophageal atresia the Conflux line of advanced systems for cancer patient care, were highlighted as an example of innovative products and technology spanning both pediatric and adult patient care.